LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Strona główna・Stock List・Boston Scientific Corp.

Boston Scientific Corp.

Closed

Sector Healthcare

81.59 0.31

Buy Sell

Overview

Share price change

24h

Current

Min

81.29

Max

81.65

Key metrics
By Trading Economics
Income	-168M 324M
Sales	260M 4.1B
P/E Sector Avg	64.71 103.001
EPS	0.62
Profit margin	7.864
Employees	48,000
EBITDA	-173M 808M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+7.67 upside

Dividends
By Dow Jones
Next Earnings	24 paź 2024

Market Stats
By TradingEconomics
Market Cap	617M 120B
Previous open	81.28
Previous close	81.59

News Sentiment

By Acuity

30%

70%

56 / 365 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

79.9 / 81.79 Support & Resistance

Boston Scientific Corp. Chart

Related News

18 cze 2024, 13:23 UTC

Acquisitions, Mergers, Takeovers

Correction to Boston Scientific to Buy Silk Road Article

18 cze 2024, 11:41 UTC

Major Market Movers

Acquisitions, Mergers, Takeovers

Silk Road Medical Shares Surge Premarket on Boston Scientific Deal

18 cze 2024, 11:31 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion

24 kwi 2024, 11:01 UTC

Earnings

Boston Scientific Lifts 2024 Outlook After Strong 1Q

24 lip 2024, 12:02 UTC

Earnings

Boston Scientific Earnings Beat; Medtech Giant Raises Guidance -- IBD

24 lip 2024, 10:48 UTC

Earnings

Boston Scientific Profit Beats Estimates As Cardiovascular Sales Surge -- MarketWatch

24 lip 2024, 10:47 UTC

Earnings

GE Vernova Delivers An Earnings Beat With First Results After Separation, Even As Revenue Misses -- MarketWatch

24 lip 2024, 10:47 UTC

Earnings

Boston Scientific Earnings Beat, Guidance Raised; Medtech Giant Rises -- IBD

24 lip 2024, 10:33 UTC

Earnings

Boston Scientific Sees 3Q Net Sales Growth of About 13%-15% >BSX

24 lip 2024, 10:32 UTC

Earnings

Boston Scientific Sees FY Net Sales Growth of About 13.5%-14.5% >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific Sees FY EPS $1.34-EPS $1.38 >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific Sees FY Adj EPS $2.38-Adj EPS $2.42 >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific 2Q Adj EPS 62c >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific 2Q EPS 22c >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific Sees 3Q Adj EPS 57c-Adj EPS 59c >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific Sees 3Q EPS 36c-EPS 38c >BSX

24 lip 2024, 10:30 UTC

Earnings

Boston Scientific 2Q Sales $4.12B >BSX

18 cze 2024, 20:22 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 14:25 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 12:54 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover -- IBD

18 cze 2024, 11:33 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Soars. It's Being Acquired by Boston Scientific. -- Barrons.com

18 cze 2024, 11:18 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical Stock Rallies On Boston Scientific Acquisition Deal -- MarketWatch

18 cze 2024, 11:03 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Sees Immaterial Impact to Adjusted EPS In 2024, 2025 >BSX

18 cze 2024, 11:02 UTC

Acquisitions, Mergers, Takeovers

Silk Road Medical to Be Acquired for $27.50/Share; Closed Monday at $21.67 >SILK BSX

18 cze 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific: Silk Road Medical Deal Reflects Enterprise Value of About $1.16 Billion >BSX SILK

18 cze 2024, 11:01 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific To Buy Silk Road Medical for $27.50/Share >BSX SILK

18 cze 2024, 11:00 UTC

Acquisitions, Mergers, Takeovers

Boston Scientific Announces Agreement To Acquire Silk Road Medical, Inc. >BSX SILK

24 kwi 2024, 12:30 UTC

Peer Comparison

Price change

Boston Scientific Corp. Forecast

Price Target

By TipRanks

7.67% upside

12 Months Forecast

Average 87.61 USD 7.67%

High 100 USD

Low 78 USD

Based on 19 Wall Street analysts offering 12 month price targets forBoston Scientific Corp. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

19 ratings

Buy

Hold

Sell

Based on 19 analysts giving stock ratings to Boston Scientific Corp. - Dist in the past 3 months.

Technical Score

By Trading Central

79.9 / 81.79Support & Resistance

Bullish events outweigh bearish events.

There is one bullish event.

Sentiment

By Acuity

56 / 365 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Boston Scientific Corp.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.